Cargando…

Effects of Renin-Angiotensin-Aldosterone System Inhibition on Left Ventricular Hypertrophy, Diastolic Function, and Functional Status in Patients With Hypertrophic Cardiomyopathy: A Systematic Review

The renin-angiotensin-aldosterone system (RAAS) plays a vital role in cardiovascular homeostasis by regulating blood pressure, salt, and water balance. The kidneys produce renin which converts angiotensinogen to angiotensin-1 (AT-I) and angiotensin-converting enzyme (ACE) to angiotensin-II (AT-II)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Akhtar, Hamza, Al Sudani, Hussein, Hussein, Muhammad, Farhan, Mehr un Nisa, Elkholy, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356743/ https://www.ncbi.nlm.nih.gov/pubmed/35949750 http://dx.doi.org/10.7759/cureus.26642

Ejemplares similares

Subaortic Membrane Co-existing With Hypertrophic Cardiomyopathy: A Clinically Challenging Diagnosis
por: Farhan, Mehr un Nisa, et al.
Publicado: (2022)

Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19: A Meta-Analysis and Systematic Review
por: Hassib, Mohab, et al.
Publicado: (2021)

An Overview of Clinically Imperative and Pharmacodynamically Significant Drug Interactions of Renin-Angiotensin-Aldosterone System (RAAS) Blockers
por: Maideen, Naina Mohamed Pakkir, et al.
Publicado: (2022)

Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19)
por: Banwait, Ranjit, et al.
Publicado: (2021)

Renin-Angiotensin-Aldosterone System (RAS) Inhibitors May Suppress the Prevalence of Peripheral Arterial Disease (PAD) in Elderly, Chronic Hemodialysis Patients
por: Tomaru, Ryo
Publicado: (2022)

Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?
por: Park, Jae-Hyeong
Publicado: (2023)

Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy
por: CIAMPI, QUIRINO, et al.
Publicado: (2006)

A systematic review of nonsynonymous single nucleotide polymorphisms in the renin–angiotensin–aldosterone system
por: Rechciński, Tomasz, et al.
Publicado: (2022)

Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
por: Koniari, Ioanna, et al.
Publicado: (2023)

Left Ventricular Diastolic Function: Comparison of Slow Coronary Flow Phenomenon and Left Ventricular Hypertrophy in the Absence of Obstructive Coronary Disease
por: Semerdzhieva, Niya E, et al.
Publicado: (2022)

Cardiac Sarcoidosis With Elevated Cardiac Troponin Mimicking Acute Myocardial Ischemia: A Case Report
por: Casipit, Bruce C, et al.
Publicado: (2023)

A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion
por: Elkholy, Karim O, et al.
Publicado: (2020)

Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States
por: Kanugula, Ashok Kumar, et al.
Publicado: (2023)

The Effect of FGF23 on Cardiac Hypertrophy Is Not Mediated by Systemic Renin-Angiotensin- Aldosterone System in Hemodialysis
por: Dörr, Katharina, et al.
Publicado: (2022)

Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy
por: Rodriguez-Gonzalez, Moises, et al.
Publicado: (2020)

The Association Between COVID-19 Mortality and ICU Admission Rates and Prior History of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hospitalized COVID-19 Patients With Hypertension in Michigan
por: Elhouderi, Eiman, et al.
Publicado: (2023)

INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy—a Randomised Intervention Trial with losartan)
por: Olivotto, Iacopo, et al.
Publicado: (2015)

Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Risk Assessment Using the Association Between Renin-Angiotensin Genes Polymorphisms and Coronary Artery Disease
por: Riad, Mohamed, et al.
Publicado: (2021)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
por: Stiefel, P., et al.
Publicado: (2011)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2014)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Interactions of the DASH Diet with the Renin-Angiotensin-Aldosterone System
por: Maris, Stephen A, et al.
Publicado: (2019)

Erratum for The renin‐angiotensin‐aldosterone system and its suppression
Publicado: (2019)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
por: Hirooka, Kazuyuki, et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022)

Are "functionally related polymorphisms" of renin-angiotensin-aldosterone system gene polymorphisms associated with hypertension?
por: Hahntow, Ines N, et al.
Publicado: (2010)

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2022)

Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients
por: Park, Chan Soon, et al.
Publicado: (2023)

Effect of intrarenal renin-angiotensin-aldosterone system on renal function in patients after cardiac surgery
por: Niu, Peiyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3dg2vt523m3b2mnsp50n3osmsh